Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold ... - PharmaLive.com (press release)
... of FineTech Laboratories, Ltd. and a $9.2 million asset impairment charge related to Par's purchase of the new drug application (NDA) for Isoptin(R) SR. ...